A Pilot Study Of Pharmacotherapy (Naltrexone) For Hazardous Drinking Among Women Infected With HIV
| Autor: | Mary Young, D. Mai, Mobeen H. Rathore, Kathleen M. Weber, Manju Karki, Robert L. Cook, Xin Hu, Mardge H. Cohen, G. Thomas, Kathleen A. Thoma |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
medicine.medical_specialty
business.industry Health Policy Human immunodeficiency virus (HIV) Public Health Environmental and Occupational Health Clinical settings Placebo medicine.disease_cause Naltrexone law.invention Pharmacotherapy Randomized controlled trial law Internal medicine medicine Hazardous drinking Psychiatry business medicine.drug |
| Zdroj: | Value in Health. 16(3) |
| ISSN: | 1098-3015 |
| DOI: | 10.1016/j.jval.2013.03.312 |
| Popis: | Methods: The NIAAA-sponsored pilot study was a double-blind, randomized controlled trial. Women with HIV who met criteria for past-year hazardous drinking were recruited from HIV clinical settings in Jacksonville (FL) and the Women’s Interagency HIV Study (WIHS) in Chicago (IL) and Washington DC. Participants were randomized 2:1 to oral naltrexone (50mg) or placebo for 4 months; outcomes were assessed 2, 4 and 7 months after enrollment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect